Search

The integration of artificial intelligence (AI) into healthcare systems has revolutionized clinical analytics, enabling enhanced diagnostic accuracy, predictive modeling, and personalized treatment pathways. However, the opacity of many AI models poses significant challenges to their clinical adoption, necessitating advancements in explainable AI (XAI) to ensure interpretability and transparency. This narrative review synthesizes the literature on XAI within clinical systems, focusing on interpretability mechanisms, transparency frameworks, and deployment constraints in healthcare analytics. Drawing from high-impact studies, we examine how XAI addresses the “black box” nature of machine learning models in high-stakes medical decisions, particularly in contexts where performance has traditionally been prioritized over explainability. Key themes include the shift toward inherently interpretable models for critical applications, such as diagnostic imaging and predictive analytics, where post-hoc explanations often fall short. We explore the ethical imperatives for responsible AI deployment, including strategies for mitigating harm through transparent systems that align with clinical workflows. The review integrates perspectives on XAI in clinical diagnostics, emphasizing challenges in balancing model complexity with user trust. Transparency is framed not merely as a technical feature but as a systemic requirement, incorporating structured reporting practices for AI interventions and standardized modeling approaches. Deployment constraints are analyzed through the lens of real-world integration, including regulatory considerations, data privacy concerns, and human–AI interaction dynamics in healthcare infrastructures. We synthesize evidence from diverse applications, such as lung cancer diagnosis via explainable models and radiographic assessments, underscoring the need for multidisciplinary approaches to XAI. Furthermore, the review highlights biases in AI systems, particularly sex and gender disparities, and advocates for inclusive analytics to foster equitable healthcare. Clinical applications beyond the black box are discussed, with calls for standardized reporting to enhance reproducibility and trust. We position XAI as essential for closed-loop systems that incorporate feedback mechanisms, ensuring ongoing model recalibration in dynamic clinical environments. The synthesis reveals persistent gaps in current XAI deployments, such as overreliance on surrogate explanations that may mislead clinicians. Ultimately, this review proposes a systems-level framework for XAI in healthcare, integrating data ingestion, inference, decision support, and governance loops to overcome transparency barriers. This comprehensive overview informs the development of future AI-enabled healthcare infrastructures, emphasizing interpretability as a cornerstone for safe and effective clinical analytics.

The integration of artificial intelligence into clinical decision support systems offers improved diagnostic accuracy and efficiency, but the opacity of many machine learning models raises concerns about trust, accountability, and regulatory compliance. Explainable artificial intelligence (XAI) has been proposed to address this by making model predictions interpretable to clinicians; however, its true clinical value remains uncertain, and evaluation has not kept pace with methodological development. This systematic review aimed to identify XAI methods used in clinical decision support systems, assess how they are evaluated with clinicians, and determine whether explanations improve diagnostic accuracy, trust, mental models, and efficiency. Following PRISMA guidelines, we searched PubMed, Web of Science, IEEE Xplore, ACM Digital Library, and Scopus for studies published between 2017 and 2024. Eligible studies included original research evaluating XAI in clinical decision support systems with clinician participants and reporting quantitative or qualitative outcomes. Risk of bias was assessed using adapted QUADAS-2 and ROBIS tools, and findings were synthesized narratively with subgroup analyses. From 2,847 records, 68 studies were included. The most common XAI methods were SHAP-based feature attribution (38%), saliency or heatmap methods (29%), concept-based approaches such as TCAV (15%), and counterfactual or example-based explanations (12%). Radiology was the dominant field (54%), followed by dermatology (18%) and pathology (12%). Evaluation approaches were highly inconsistent, with few validated instruments and most studies relying on Likert-scale trust measures or qualitative feedback. Only 16% of studies showed improved diagnostic accuracy with explanations, 67% showed no significant effect, and 17% reported reduced accuracy due to over-reliance or misinterpretation. Although 82% of studies reported increased clinician trust, trust rarely correlated with actual diagnostic performance. Overall, while XAI methods are widely studied in clinical decision support, their evaluation is inconsistent and their benefits are limited. Explanations tend to increase clinician trust without reliably improving diagnostic accuracy, and may sometimes worsen performance, highlighting a trust–accuracy gap that poses important safety concerns for clinical deployment.

Postpartum hemorrhage (PPH) is the leading cause of maternal mortality worldwide, accounting for 25–30% of deaths, particularly in low-resource settings, and early identification of high-risk patients during labor could enable timely interventions such as uterotonic administration, blood preparation, and escalation of care; however, current risk stratification models rely mainly on static antepartum factors and fail to incorporate dynamic intrapartum physiological changes. Existing tools, including those from the California Maternal Quality Care Collaborative, use baseline maternal characteristics such as prior PPH, BMI, parity, and comorbidities, but do not capture continuously evolving labor data, despite intrapartum signals like fetal heart rate patterns, maternal vital sign trends, and labor progression metrics containing rich predictive information that remains underused in real-time decision-making, while clinical judgment is limited by inter-observer variability and inability to integrate complex temporal trends. To address this gap, we propose an explainable gradient boosting machine framework for real-time PPH risk prediction that integrates electronic fetal monitoring parameters (baseline rate, variability, decelerations), maternal vital signs (heart rate, blood pressure, temperature, oxygen saturation), and labor progression features (cervical dilation, contraction frequency, stage duration, and oxytocin use), producing continuously updated risk scores throughout labor. The system combines a gradient boosting model (XGBoost or LightGBM), a SHAP-based explainability module, a real-time feature extraction pipeline, and a clinician-facing dashboard that displays risk scores and key contributing factors, where SHAP provides both global and patient-specific interpretability by identifying how features such as tachysystole or prolonged labor stages influence predictions, thereby improving transparency and clinical trust. Overall, this framework enables dynamic, interpretable PPH risk assessment using routinely collected intrapartum data, combining predictive accuracy with explainability to support earlier detection of hemorrhage risk and more timely, targeted interventions.

Anticoagulation management requires balancing multiple factors such as bleeding risk, thromboembolic risk, drug interactions, and renal function. Deep learning can assist in risk prediction, but its effectiveness relies on clinicians' ability to understand and verify the recommendations. Black-box models may recommend actions without providing clear explanations. In contrast, clinical guidelines are rule-based but not directly executable by neural models. This article introduces a neuro-symbolic XAI framework that combines deep learning predictions with explicit clinical guidelines. It includes a neural prediction module, a symbolic reasoning engine, and an integration layer for traceable justifications. The neuro-symbolic approach connects data-driven predictions to clinical rules, improving auditability and trustworthiness in decision support. This framework aims to enhance anticoagulation management by providing verifiable, clinician-understandable decision support, focusing on explainability-by-design.

Emergency department discharge delays are a critical operational bottleneck shaped by diagnostic completion intervals, inpatient bed scarcity, consultant responsiveness, and patient acuity. Understanding these drivers in real time is essential for improving flow and reducing avoidable crowding. Current ED analytics often describe aggregate delays after they occur. Clinicians and operational managers therefore lack transparent patient-level tools that indicate which factor is most responsible for a specific delayed discharge episode. This article proposes an explainable gradient-boosting framework for identifying key contributors to delayed ED discharge. The framework focuses on diagnostic order completion times, bed availability, consultant response delays, and patient acuity scores. The proposed framework uses a gradient-boosted tree ensemble trained on historical ED visit data and paired with SHAP-based post-hoc explanations. It is designed conceptually for real-time use with live electronic health record, bed-board, order, and consultation data. Conceptually, the framework would generate both a delay-risk score and an interpretable decomposition of that risk. These explanations could support targeted actions such as expediting a pending diagnostic test, escalating bed-management review, or re-contacting a delayed consultant service. The framework would shift ED discharge management from reactive reporting toward proactive operational decision support. Explainability is positioned as the foundation for clinician trust, workflow alignment, and accountable deployment.

Machine learning is increasingly used in hospital operations, revenue cycle management, and quality monitoring. These administrative applications require transparency because their outputs can influence access, resource allocation, financial decisions, and accountability. This systematic review examined explainable machine learning methods applied to operational decision support, revenue cycle analytics, and quality monitoring in healthcare administration. The review focused on the type, depth, and use of transparency methods rather than predictive performance. A PRISMA 2020–compliant search strategy was applied to PubMed, Scopus, IEEE Xplore, and Web of Science for studies published between 2017 and 2022. Screening, extraction, and narrative synthesis focused on administrative domain, model type, explanation method, stakeholder use, and risk of bias. SHAP and LIME were the most frequently discussed post-hoc explanation approaches, while feature importance, partial dependence, rule-based models, and attention mechanisms appeared in smaller subsets of the literature. Operational decision support showed the strongest explainability uptake, whereas revenue cycle analytics and administrative quality monitoring remained less developed. Explainability in healthcare administration remains uneven and often superficial. The largest gap is not the availability of explanation tools, but the limited evidence that explanations improve managerial decisions, accountability, fairness, or auditability.

Claim denials represent a major source of lost or delayed healthcare revenue. They are commonly driven by documentation gaps, coding inconsistencies, payer rule violations, and missing or invalid prior authorizations. Current denial prevention often depends on manual review and deterministic claim-scrubbing rules. These approaches may not capture complex payer-specific interactions among documentation quality, procedure codes, diagnosis codes, and authorization history. This article proposes an explainable gradient boosting model for estimating the probability that a health insurance claim could be denied before submission. The model is intended to identify the specific claim-level factors contributing to denial risk. The proposed framework uses a gradient-boosted tree ensemble trained conceptually on historical claims and remittance data. SHAP-based explanations would provide both global and local interpretability for denial-risk predictions. Conceptually, the model would return a denial risk score alongside an explanation of contributing factors such as incomplete documentation, diagnosis-code mismatch, expired authorization, or payer rule conflict. These outputs would support targeted pre-billing review rather than broad manual auditing. An explainable denial prediction model could help shift revenue cycle management from reactive appeals toward proactive prevention. Transparent reasoning would be essential for revenue cycle staff, clinical documentation teams, coders, and compliance stakeholders.

Laboratory alert fatigue erodes the effectiveness of clinical decision support by making repeated abnormal result notifications less likely to prompt timely clinical attention. It is often recognised only after providers begin delaying, overriding, or ignoring alerts. Current alert reduction strategies are commonly based on broad thresholds or blanket suppression rules. These approaches do not explain which providers, specialties, alert types, or repeated result patterns are most susceptible to fatigue. This article proposes an interpretable machine learning model that could predict whether a provider will exhibit fatigued behaviour toward a specific laboratory alert. The model is intended to support transparent, provider-aware alert redesign rather than opaque automation. The proposed framework would use historical alert logs with features capturing alert frequency, clinical severity, provider specialty, repeated abnormal results, response time history, and override behaviour. A regularised logistic regression or gradient-boosted tree model with SHAP explanations would provide both prediction and interpretability. Conceptually, the model would generate a fatigue risk score for each provider–alert pair. It would also attribute the score to specific drivers, such as repeated low-severity results, accumulated alert burden, or recent override patterns. An interpretable fatigue prediction model could enable personalised alert suppression, escalation, or redesign before a clinically important laboratory result is missed. Such a system would support safer, more adaptive clinical decision support.

Specialty referral pathways are a critical point at which healthcare inequities can emerge. Referral decisions may be shaped by insurance status, race, language, documentation practices, diagnosis severity, and the structure of available provider networks. Health systems often lack scalable and explainable tools for detecting inequitable referral patterns as they occur. As a result, discriminatory or structurally biased patterns may remain hidden within routine clinical operations. This article develops a conceptual explainable artificial intelligence model for identifying whether demographic or insurance factors unduly influence specialty referral decisions after accounting for clinical severity. The model is designed to support transparent, fairness-oriented referral analytics rather than replace clinical judgment. The proposed model uses a gradient-boosted classification framework trained on referral-eligible primary care encounters. Input features include patient demographics, insurance type, diagnosis severity, primary care note-derived complexity and completeness features, and provider network metrics, with SHAP-based explanation layers used for fairness auditing. Conceptually, the model could flag encounters in which predicted referral likelihood diverges from clinically expected patterns. These flags would be interpreted through explanation methods that attribute potential inequitable influence to insurance, demographic, documentation, or network-related factors. The model could help health systems audit, explain, and intervene on systemic specialty referral bias. Its central contribution is a transparent framework for moving referral equity work from retrospective description toward proactive, data-driven fairness review.

Clinical pathways are designed to standardize inpatient care for common conditions while allowing clinically justified individualization. Deviations from these pathways are frequent and may reflect either appropriate adaptation to patient complexity or potentially harmful departure from evidence-informed practice. Current deviation detection often depends on retrospective audit, static compliance rules, or aggregate dashboards. These approaches can miss subtle temporal drift in care delivery and rarely explain why a specific patient trajectory diverged from the expected pathway. This article proposes an interpretable machine learning model for detecting clinical pathway deviations in hospitalized patients. The model focuses on order sequences, vital sign trends, laboratory monitoring frequency, and provider decision patterns as dynamic indicators of care-process variation. Conceptually, the model would compare each patient’s evolving care trajectory with learned expected pathways using sequence-comparison and outlier-detection logic. SHAP-based or attention-informed explanations would identify the specific features responsible for a deviation flag, such as delayed monitoring, omitted follow-up testing, or unusual ordering behavior. The proposed model could detect when a patient’s care trajectory diverges from an expected pathway and provide a transparent rationale for review. For example, it could flag a missing repeat troponin, a delayed antibiotic escalation, or a laboratory monitoring pattern inconsistent with the patient’s clinical state. An interpretable pathway-deviation model could shift quality monitoring from manual, sample-based review toward continuous and transparent pathway surveillance. Such a system would support real-time clinical awareness, structured audit, and organizational learning.

Case management programs are intended to reduce avoidable utilization and improve coordination for patients with complex medical, social, and engagement needs. Because case management capacity is limited, health systems need prioritization tools that are both clinically sensible and transparent. Existing referral methods often rely on clinician judgment, simple utilization thresholds, or proprietary risk scores that provide limited explanation. These approaches may overlook social needs, missed appointments, and care gaps that shape patient complexity and influence whether an intervention is feasible. This article proposes an explainable machine learning model that stratifies patients by risk of future high utilization and provides patient-specific reasoning. The model is designed around prior utilization, chronic disease burden, social needs documentation, missed appointments, and care gap indicators. The conceptual architecture uses a gradient-boosted classification model with a SHAP-based post-hoc explanation layer. The model would output both a risk score and a ranked list of contributing factors for each patient considered for case management referral. Conceptually, the model would identify patients who may benefit from case management and explain why each patient was prioritized. These explanations could help case managers tailor outreach, match patients to intervention pathways, and distinguish medical complexity from social instability or disengagement. An explainable risk stratification model could turn a blind referral process into a transparent, clinically sensible prioritization workflow. Its value would depend on careful implementation, fairness monitoring, and alignment with real case manager decision-making.

Prior authorization delays impede timely patient care and contribute to administrative pressure across clinical and revenue cycle workflows. These delays can affect scheduling, medication access, procedural planning, and patient confidence in the care process. Current authorization management tools are largely reactive and often focus on tracking request status after submission. They rarely predict which requests are likely to experience approval delays or explain the operational, clinical, or payer-specific reasons behind those delays. This article proposes an interpretable machine learning model for predicting the likelihood of prior authorization approval delays. The model is designed to provide transparent, request-level explanations that can guide pre-submission correction and authorization preparation. The proposed framework uses a gradient-boosted tree model trained conceptually on historical authorization requests. Inputs include payer-specific rules, clinical documentation features, procedure type, medical necessity indicators, and historical approval timelines, with SHAP used to attribute predicted delay risk to individual features. Conceptually, the model would output a delay probability and an explanation of the dominant drivers of that prediction. These drivers could include incomplete documentation, mismatch with payer medical necessity criteria, procedure categories associated with additional review, or payer-procedure combinations with historically slow turnaround. An interpretable prior authorization delay model could support earlier correction of incomplete requests, reduce administrative waste, and improve patient access. By aligning predictive analytics with transparent explanations, the framework could make authorization preparation more proactive and accountable.

Clinical triage algorithms increasingly influence access to emergency care, specialty referral, admission, and follow-up. As patient populations and clinical practice patterns change, these systems can silently drift toward biased performance. Current fairness assessments are often retrospective, episodic, and disconnected from operational triage workflows. They may identify inequity after harm has already accumulated rather than detecting emerging bias as it develops. This article proposes an explainable AI model for continuous monitoring of algorithmic bias in clinical triage systems. The model focuses on demographic drift, outcome disparities, prediction confidence, and referral decision patterns as complementary bias signals. The proposed model uses operational triage logs, demographic distributions, prediction outputs, outcome indicators, and referral decisions to generate a conceptual fairness risk signal. SHAP-based explanation modules decompose the signal into interpretable contributors for clinical governance teams. Conceptually, the model would detect divergence in referral patterns across demographic groups, identify whether the divergence coincides with demographic drift, flag subgroup-specific prediction confidence concerns, and explain the likely drivers of the alert. The output would support timely review rather than automated punitive action. The model could transform algorithmic fairness from a periodic retrospective report into a continuous, transparent, and operationally actionable surveillance system. It is designed as a governance-oriented framework rather than an experimental performance claim.

Many patients discharged from emergency departments require timely outpatient follow-up to complete diagnostic, therapeutic, or monitoring plans. When follow-up is delayed, unresolved symptoms, missed diagnoses, medication problems, and preventable return visits may occur. Current discharge workflows often rely on generic instructions and assume that patients can understand, schedule, and attend recommended care. Existing prediction approaches do not consistently combine unstructured discharge instructions, appointment access, portal engagement, social risk, and visit severity in a transparent way.This article proposes a transparent machine learning framework for predicting delayed follow-up after emergency department visits. The objective is to support patient-specific discharge planning by identifying both the likelihood of delay and the most actionable contributing barriers. The proposed model would combine structured emergency department and scheduling data with natural language processing features extracted from discharge instructions. A gradient-boosted tree model with SHAP-based explanations would provide patient-level and population-level interpretability. Conceptually, the model would identify patients at elevated risk of delayed follow-up and attribute that risk to factors such as unclear instructions, limited appointment availability, absent portal engagement, transportation barriers, or higher visit complexity. These explanations would be intended to guide targeted interventions rather than replace clinical judgment. A transparent model for delayed follow-up prediction could enable precision transitional care after emergency department discharge. By aligning predictions with actionable explanations, care teams could direct limited resources toward the specific barrier most likely to prevent timely follow-up.